Table: Rohto -2019/20 group results

Rohto Pharmaceutical

12/05/2020 07:00

May 12 (Reuters)- 
          Rohto Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Mar 31, 2020    Mar 31, 2019   Mar 31, 2021     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales            188.33          183.58         183.00                 
                 (+2.6 pct)      (+6.9 pct)     (-2.8 pct)               
  Operating         23.09           20.81          21.80                 
                 (+10.9 pct)     (+9.0 pct)     (-5.6 pct)               
  Recurring         22.74           18.97          22.10                 
                 (+19.8 pct)     (+0.6 pct)     (-2.8 pct)               
  Net
  Net               15.41            9.80          14.00                 
                 (+57.3 pct)     (+5.5 pct)     (-9.2 pct)               
  EPS            135.13 yen       86.00 yen     122.73 yen               
  EPS Diluted    134.71 yen       85.66 yen                              
  Ann Div         26.00 yen       25.00 yen      27.00 yen               
  -Q2 Div         13.00 yen       11.00 yen      13.00 yen               
  -Q4 Div         13.00 yen       14.00 yen      14.00 yen               
  
  NOTE - Rohto Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T